Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines

Onderstepoort Journal of Veterinary Research

Volumn 65, Issue 4, 1998, Pages 321-329

  Du Plessis, M ^b   Cloete, M ^a,b   Aitchison, H ^c   Van Dijk, A A ^b  

^a Roodeplaat Veg Ornamental Plant I   (South Africa)

^b ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^c Onderstepoort Biological Products   (South Africa)

Author keywords

African horsesickness virus; Baculovirus; Serotype 5 VP2; Vaccines

Indexed keywords

AFRICAN HORSESICKNESS VIRUS; CAVIA; EQUIDAE; UNIDENTIFIED BACULOVIRUS;

RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY;

AFRICAN HORSE SICKNESS VIRUS; ANIMAL; ANIMAL DISEASE; ARTICLE; BACULOVIRUS; BIOSYNTHESIS; BLOOD; CLASSIFICATION; GENE VECTOR; GENETICS; GUINEA PIG; HORSE; HORSE DISEASE; IMMUNOLOGY; METHODOLOGY; MOLECULAR CLONING; VACCINATION;

AFRICAN HORSE SICKNESS VIRUS; ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CLONING, MOLECULAR; GENETIC VECTORS; GUINEA PIGS; HORSE DISEASES; HORSES; RECOMBINANT PROTEINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0032248341     PISSN: 00302465     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BREMER, C.W. 1976. A gel electrophoretic study of the protein and nucleic acid components of African horsesickness virus. Onderstepoort Journal of Veterinary Research, 43:193-200.
2. ERASMUS, B.J. 1963. Preliminary observations of the value of the guinea pig in determining the innocuity and antigenicity of neurotropic attenuated horsesickness strains. Onderstepoort Journal of Veterinary Research, 30:11-22.
3. ERASMUS, B.J. 1977. Arbovirus vaccines: Veterinary aspects, in Medicine in a Tropical Environment. Proceedings of the International Symposium, Pretoria 19-23 July 1976. South Africa, edited by J.H.S. Gear. A.A. Balkema, Cape Town.
4. ERASMUS, B.J., YOUNG, E., PIETERSE, L.M. & BOSHOFF, S.J. 1978. The susceptibility of zebra and elephants to African horsesickness virus, in Equine Infectious Diseases, Proceedings of the Fourth International Conference on Equine Infectious Diseases, 24-27 September 1976 in Lyon, France, edited by J.T. Bryan & H. Gerber. Princeton, New Jersey: Veterinary Publications, Inc.
5. rd ed. Pretoria: Central News Agency Ltd.
6. HUISMANS, H. & ERASMUS, B.J. 1981. Identification of the serotype-specific and group-specific antigens of bluetongue virus. Onderstepoort Journal of Veterinary Research, 48:51-58.
7. HUISMANS, H., VAN DER WALT, N.T., CLOETE, M. & ERASMUS, B.J. 1987. Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep. Virology, 157:172-179.
8. LAEMMLI, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227:680-685.
9. LAMBDEN, P.L., COOKE, S.J., CAUL, E.O. & CLARKE, I.N. 1992. Cloning of non-cultivatable human rotavirus by single primer amplification. Journal of Virology, 66:1817-1822.
10. LUCKOW, V.A., LEE, S.C., BARRY, G.F. & OLINS, P.O. 1993. Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. Journal of Virology, 67:4566-4579.
11. MARTINEZ-TORRECUADRADA, J.L., IWATA, H., VENTEO, A., CASAL, I., & ROY, P. 1994. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization. Virology, 202:348-359.
12. MARTINEZ-TORRECUADRADA, J. L., DIAZ-LAVIADA, M., ROY, P., SANCHEZ, C., VELA, C., SANCHEZ-VIZCAINO, J.M. & CASAL, J.I. 1996. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7. Journal of General Virology, 77:1211-1221.
13. MARTYN, J.C., GOULD, A.R. & YU, M. 1994. Expression of the outer capsid proteins VP2 and VP5 of bluetongue virus in Saccharomyces cerevisiae. Virus Research, 33:11-25.
14. MEISWINKEL, R., NEVILL, E.M. & VENTER, G.J. 1994. Vectors: Culicoides spp., in Infectious Disease of Livestock, edited by J.A.W. Coetzer, G.R. Thomson & R.C. Tustin. Cape Town: Oxford University Press.
15. ROY, P., URAKAWA, T., VAN DIJK, A.A. & ERASMUS, B.J. 1990. Recombinant virus vaccine for bluetongue disease in sheep. Journal of Virology, 64:1998-2003.
16. ROY, P. BISHOP, D.H.L., LEBLOIS, H. & ERASMUS, B.J. 1994. Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection. Vaccine, 12: 805-811.
17. ROY, P., MERTENS, P.P.C. & CASAL, I. 1994. African horse sickness virus structure. Comparative Immunology Microbiology and Infectious Diseases, 17:243-273.
18. ROY, P., BISHOP, D.H.L., HOWARD, S. AITCHISON, H. & ERASMUS, B.J. 1996. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge. Journal of General Virology, 77:2053-2057.
19. SAMBROOK, J., FRITSCH, E.F. & MANIATIS, T. 1989. Molecular Cloning - A Laboratory Manual. Cold Spring Harbor, New York, USA: Laboratory Press.
20. SAKAMOTO, K., MIZUKOSHI, N., APIWATNAKORN, B., IWATA, A., TSUCHIYA, T., UEDA, S., IMAGAWA, H., SUGIURA, T., KAMADA, M. & FUKUSHO, A. 1994. The complete sequences of African horsesickness virus serotype 4 (vaccine strain) RNA 2 and 6 which encode outer capsid protein. Journal of Veterinary Medical Science, 56:321-327.
21. STONE-MARSCHAT, M.A., MOSS, S.R., BURRAGE, T.G., BARBER, M.L., ROY, P. & LAEGREID, W.W. 1996. Immunization with VP2 is sufficient for protection against lethal challenge with African horsesickness virus type 4. Virology, 220:219-222.
22. SWANEPOEL, R., ERASMUS, B.J., WILLIAMS, R. & TAYLOR, M.B. 1991. Encephalitis and chorioretinitis associated with neurotropic African horsesickness virus infection in laboratory workers, III. Virological and serological investigations. South African Medical Journal, 81:458-461.
23. VAN DIJK, A.A. African horsesickness vaccine development. Proceedings of the Eighth International Conference on Equine Infectious Diseases, 23-28 March 1998, Dubai, United Arab Emirates, edited by J.F. Wade. Newmarket, UK: R&W Publications Ltd (in press).
24. VAN DIJK, A.A. & HUISMANS, H. 1982. The effect of temperature on the in vitro transcriptase reaction of bluetongue virus, epizootic haemorrhagic disease virus and African horsesickness virus. Onderstepoort Journal of Veterinary Research, 49:227-232.
25. VERWOERD, D.W. 1969. Purification and characterization of bluetongue virus. Virology, 38:203-212.
26. VREEDE, F.T. & HUISMANS, H. 1994. Cloning, characterization and expression of the gene that encodes the major neutralization-specific antigen of African horsesickness virus serotype 3. Journal of General Virology, 75:3629-3633.
27. VREEDE, F.T., CLOETE, M., NAPIER, G.B., VAN DIJK, A.A. & VILJOEN, G.J. 1998. Sequence-independent amplification and cloning of large dsRNA virus genome segments by poly(dA)-oligonucleotide ligation. Journal of Virological Methods, 72: 243-247.
28. WILLIAMS, C.F., INOUE, T., LUCUS, A-M., ZANOTTO, P.M. DE A. & ROY, P. 1998. The complete sequence of four major structural proteins of African horse sickness virus serotype 6: evolutionary relationships within and between orbiviruses. Virus Research, 53:53-73.
29. YON, J.M. 1996. The specificity of protein aggregation. Nature Biotechnology, 14:1231.